QLTI: 3.36 +0.35 (11.63%) - QLT Inc. (USA): "# Range 3.01 - 3.51
# 52 week 1.40 - 4.09
# Open 3.07
# Vol / Avg. 1.61M/287,000.00
# Mkt cap 183.52M
# P/E 9.81
# Div -
# EPS 0.34
# Shares 54.62M
# Beta 1.33
# Inst"
TORONTO (DOW JONES)--QLT Inc.'s (QLTI) shares are up nearly 60% so far this month, a move the company's top executive says isn't surprising given how low the stock sank.
"I think we're moving towards a more reasonable valuation," said QLT Chief Executive Bob Butchofsky in an interview with Dow Jones. He added that QLT was recently trading below cash value, but has recovered along with other stocks in the ophthalmology sector.
On Nasdaq Monday, QLT is up 37 cents, or 12%, to $3.38 on 187,000 shares. The stock traded as low as $1.40 in March, and is at its highest level since September.
QLT Inc. (QLT), is a global biopharmaceutical company engaged in the business of discovering, developing and commercialization of therapies. QLT has two commercial products, Visudyne and Eligard. Visudyne utilizes photodynamic therapy (PDT), to treat the eye disease known as wet age related macular degeneration (wet AMD), the cause of blindness in people over the age of 55 in North America and Europe. Visudyne is also used for the treatment of subfoveal choroidal neovascularization (CNV) due to pathologic myopia, or severe near-sightedness, and presumed ocular histoplasmosis or other macular diseases. The Eligard product line includes one, three, four and six month commercial formulations of Atrigel technology combined with leuprolide acetate.
www.stockcaps.blogspot.com
![]() | Company Earnings Earnings Dates, Surprises, Conference Calls | ![]() | Financial Calendars Stock Splits, Economic, IPOs, Mergers |
![]() | Analyst Research Report Screener, Analyst Performance Center, Up/Downgrades, Sector/Industry Analysis | ![]() | Research Tools Stock Screener, Historical Quotes, Real-Time Quotes |
![]() | Company Reports Annual Reports, SEC Filings, Financial Statements | ![]() | Bonds Bond Center, Bond Screener, Bond News, Bond Rates |
![]() | Mutual Funds Mutual Fund Center, Fund Screener, Top Performers | ![]() | Options Options Center, Options News, Options 101 |
Top Stories
Monday, July 27, 2009
Subscribe to:
Post Comments (Atom)
Wall Street Journal What's News
TheStreet Search RSS Feed: Cramer's Take: C
Money, Markets & More
Wall Street Journal This Morning
Wall Street Journal's Your Money Matters
Wall Street Journal Tech News Briefing
MarketWatch Internet Daily
MarketWatch Morning Stock Talk
Care2 News Network - Brain Food found by tapinder k.
WSJ.com Video - News/Analysis
Personal Journal
Weekend Journal
Weekend & Leisure
WSJ.com: Law
WSJ.com: Asia Markets News
WSJ.com: Health
WSJ.com: Media & Marketing
Wall Street Journal
News & Commentary
WSJ.com: Markets
WSJ.com: Europe Markets News
WSJ.com: Deals & Deal Makers
WSJ.com: Hedge Funds
Money and Investing
NEWSPAPER- Page One
Forums
Homes
Sports
Books
Careers
Health
Gadgets
Travel
Autos
Money
Tecnology
whats new
No comments:
Post a Comment